Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 274-282

  Kang, Fu Biao ^a,b   Wang, Ling ^c   Li, Dong ^b   Zhang, Yin Ge ^b   Sun, Dian Xing ^a,b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

B7 H3; Hepatocellular carcinoma; STAT signaling pathway; Tumor associated macrophages

Indexed keywords

ARGINASE 1; B7 HOMOLOG 3 PROTEIN; LYMPHOCYTE ANTIGEN; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; B7 ANTIGEN; CD276 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION; UPREGULATION; CELL POLARITY; COCULTURE; IMMUNOLOGY; KAPLAN MEIER METHOD; LIVER TUMOR; MACROPHAGE; METABOLISM; MIDDLE AGED; MORTALITY; PHYSIOLOGY;

B7 ANTIGENS; CARCINOMA, HEPATOCELLULAR; CELL POLARITY; COCULTURE TECHNIQUES; FEMALE; HEP G2 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; STAT3 TRANSCRIPTION FACTOR;

EID: 84916196163     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3587     Document Type: Article

References (47)

1. Flores A and Marrero JA: Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics. Clin Med Insights Oncol 8: 71-76, 2014.
2. Abdel-Rahman O: Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside. J Egypt Natl Canc Inst 25: 165-171, 2013.
3. Salomao M, Remotti H, Vaughan R, Siegel AB, Lefkowitch JH and Moreira RK: The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis. Hum Pathol 43: 737-746, 2012.
4. Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet 379: 1245-1255, 2012.
5. Rossi L, Zoratto F, Papa A, et al: Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2: 348-359, 2010.
6. Palmer DH, Midgley RS, Mirza N, et al: A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology 49: 124-132, 2009.
7. Hernandez-Gea V, Alsinet C and Llovet JM: Oncolytic immunotherapeutic virus in HCC: can it compete with molecular therapies? J Hepatol 59: 882-884, 2013.
8. Ceeraz S, Nowak EC and Noelle RJ: B7 family checkpoint regulators in immune regulation and disease. Trends Immunol 34: 556-563, 2013.
9. Sun TW, Gao Q, Qiu SJ, et al: B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunol Immunother 61: 2171-2182, 2012.
10. Wang F, Wang G, Liu T, Yu G, Zhang G and Luan X: B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression. Cancer Invest 32: 262-271, 2014.
11. Geng L, Deng J, Jiang G, et al: B7-H1 up-regulated expression in human hepatocellular carcinoma tissue: correlation with tumor interleukin-10 levels. Hepatogastroenterology 58: 960-964, 2011.
12. Wang L, Kang FB and Shan BE: B7-H3-mediated tumor immunology: friend or foe? Int J Cancer 134: 2764-2771, 2014.
13. Chapoval AI, Ni J, Lau JS, et al: B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol 2: 269-274, 2001.
14. Chen W, Liu P, Wang Y, et al: Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma. PLoS One 8: e76965, 2013.
15. Goubran HA, Kotb RR, Stakiw J, Emara ME and Burnouf T: Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer Growth Metastasis 7: 9-18, 2014.
16. Santoni M, Massari F, Amantini C, et al: Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 62: 1757-1768, 2013.
17. Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A and Jaillon S: Tumor associated macrophages and neutrophils in cancer. Immunobiology 218: 1402-1410, 2013.
18. Shirabe K, Mano Y, Muto J, et al: Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 42: 1-7, 2012.
19. Fan QM, Jing YY, Yu GF, et al: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 352: 160-168, 2014.
20. Wang L, Zhang Q, Chen W, et al: B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. PLoS One 8: e70689, 2013.
21. Liu H, Tekle C, Chen YW, et al: B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther 10: 960-971, 2011.
22. Sun J, Mao Y, Zhang YQ, et al: Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer. Oncol Lett 6: 1253-1260, 2013.
23. Zhang G, Wang J, Kelly J, et al: B7-H3 augments the inflammatory response and is associated with human sepsis. J Immunol 185: 3677-3684, 2010.
24. Tjiu JW, Chen JS, Shun CT, et al: Tumor-associated macrophageinduced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 129: 1016-1025, 2009.
25. Wang L, Kang F, Li J, Zhang J and Shan B: Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line. Cancer Cell Int 13: 14, 2013.
26. Wu TH, Li YY, Wu TL, et al: Culture supernatants of different colon cancer cell lines induce specific phenotype switching and functional alteration of THP-1 cells. Cell Immunol 290: 107-115, 2014.
27. Kabilova TO, Kovtonyuk LV, Zonov EV, et al: Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. BMC Cancer 14: 338, 2014.
28. Schmidt N, Neumann-Haefelin C and Thimme R: Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy. Dig Dis 30: 483-491, 2012.
29. Seliger B and Quandt D: The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunol Immunother 61: 1327-1341, 2012.
30. Bottino C, Dondero A, Bellora F, et al: Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches. Front Immunol 5: 56, 2014.
31. Capece D, Fischietti M, Verzella D, et al: The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int 2013: 187204, 2013.
32. Lievense LA, Bezemer K, Aerts JG and Hegmans JP: Tumorassociated macrophages in thoracic malignancies. Lung Cancer 80: 256-262, 2013.
33. Martinez FO, Sica A, Mantovani A and Locati M: Macrophage activation and polarization. Front Biosci 13: 453-461, 2008.
34. Chen C, Shen Y, Qu QX, Chen XQ, Zhang XG and Huang JA: Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Exp Cell Res 319: 96-102, 2013.
35. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006.
36. Yuan A, Chen JJ and Yang PC: Pathophysiology of tumorassociated macrophages. Adv Clin Chem 45: 199-223, 2008.
37. Yue ZQ, Liu YP, Ruan JS, Zhou L and Lu Y: Tumor-associated macrophages: a novel potential target for cancer treatment. Chin Med J 125: 3305-3311, 2012.
38. Wang H, Wang X, Li X, et al: CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway. Cancer Lett 345: 91-99, 2014.
39. Lee JH, Lee GT, Woo SH, et al: BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Cancer Res 73: 3604-3614, 2013.
40. Ma YY, He XJ, Wang HJ, et al: Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer. Cancer Sci 102: 336-342, 2011.
41. Chen C, Zhu YB, Shen Y, Zhu YH, Zhang XG and Huang JA: Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas. J Immunother 35: 354-358, 2012.
42. Chen J, Li G, Meng H, et al: Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas. Cancer Immunol Immunother 61: 101-108, 2012.
43. Chen C, Qu QX, Shen Y, et al: Induced expression of B7-H4 on the surface of lung cancer cells by the tumor-associated macrophages: a potential mechanism of immune escape. Cancer Lett 317: 99-105, 2012.
44. Tekle C, Nygren MK, Chen YW, et al: B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer 130: 2282-2290, 2012.
45. Chen X, Quinn EM, Ni H, et al: B7-H3 participates in the development of experimental pneumococcal meningitis by augmentation of the inflammatory response via a TLR2-dependent mechanism. J Immunol 189: 347-355, 2012.
46. Zhang W, Xu W and Xiong S: Macrophage differentiation and polarization via phosphatidylinositol 3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P component. J Immunol 187: 1764-1777, 2011.
47. Zhou D, Huang C, Lin Z, et al: Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 26: 192-197, 2014.